Literature DB >> 3530560

Blood pressure and hormonal responses to sublingual nifedipine in acute childhood hypertension.

W Rascher, K E Bonzel, H Ruder, D E Müller-Wiefel, K Schärer.   

Abstract

Twelve infants and children were treated with sublingual application of the calcium antagonist nifedipine. Blood pressure fell within 1 h following administration of nifedipine to age-related normal values. Whereas plasma renin activity, plasma concentrations of aldosterone and arginine vasopressin did not change within 1 h after drug application, plasma noradrenaline rose (p less than 0.05), probably in response to vasodilatation. Plasma concentration of nifedipine at 30 and 60 min after application correlated positively with the fall in mean arterial pressure. Nifedipine was well tolerated and appeared to be an effective and safe drug in the treatment of acute rises of blood pressure in infants and children.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530560     DOI: 10.3109/10641968609046605

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  4 in total

Review 1.  Hypertension in children.

Authors:  M de Swiet; M J Dillon
Journal:  BMJ       Date:  1989-08-19

2.  Sublingual nifedipine in acute severe hypertension.

Authors:  J H Evans; N J Shaw; J T Brocklebank
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

Review 3.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

Review 4.  Management of Hypertensive Crises in Children: A Review of the Recent Literature.

Authors:  Nicola Bertazza Partigiani; Rachele Spagnol; Laura Di Michele; Micaela Santini; Benedetta Grotto; Alex Sartori; Elita Zamperetti; Margherita Nosadini; Davide Meneghesso
Journal:  Front Pediatr       Date:  2022-04-15       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.